Oosterhuis D - Search Results

1

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.

Pasricha SR, Lim PJ, Duarte TL, Casu C, Oosterhuis D, Mleczko-Sanecka K, Suciu M, Da Silva AR, Al-Hourani K, Arezes J, McHugh K, Gooding S, Frost JN, Wray K, Santos A, Porto G, Repapi E, Gray N, Draper SJ, Ashley N, Soilleux E, Olinga P, Muckenthaler MU, Hughes JR, Rivella S, Milne TA, Armitage AE, Drakesmith H. Pasricha SR, et al. Among authors: oosterhuis d. Nat Commun. 2017 Sep 1;8(1):403. doi: 10.1038/s41467-017-00500-z. Nat Commun. 2017. PMID: 28864822 Free PMC article.

2

Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.

Westra IM, Oosterhuis D, Groothuis GM, Olinga P. Westra IM, et al. Among authors: oosterhuis d. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):328-38. doi: 10.1016/j.taap.2013.11.017. Epub 2013 Dec 7. Toxicol Appl Pharmacol. 2014. PMID: 24321339

3

The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.

Westra IM, Oosterhuis D, Groothuis GM, Olinga P. Westra IM, et al. Among authors: oosterhuis d. PLoS One. 2014 Apr 22;9(4):e95462. doi: 10.1371/journal.pone.0095462. eCollection 2014. PLoS One. 2014. PMID: 24755660 Free PMC article.

4

Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis.

Pham BT, van Haaften WT, Oosterhuis D, Nieken J, de Graaf IA, Olinga P. Pham BT, et al. Among authors: oosterhuis d. Physiol Rep. 2015 Apr;3(4):e12323. doi: 10.14814/phy2.12323. Physiol Rep. 2015. PMID: 25907784 Free PMC article.

5

Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo.

Poosti F, Pham BT, Oosterhuis D, Poelstra K, van Goor H, Olinga P, Hillebrands JL. Poosti F, et al. Among authors: oosterhuis d. Dis Model Mech. 2015 Oct 1;8(10):1227-36. doi: 10.1242/dmm.020172. Epub 2015 Jun 25. Dis Model Mech. 2015. PMID: 26112172 Free PMC article.

6

Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis.

Westra IM, Mutsaers HA, Luangmonkong T, Hadi M, Oosterhuis D, de Jong KP, Groothuis GM, Olinga P. Westra IM, et al. Among authors: oosterhuis d. Toxicol In Vitro. 2016 Sep;35:77-85. doi: 10.1016/j.tiv.2016.05.012. Epub 2016 May 26. Toxicol In Vitro. 2016. PMID: 27235791

7

In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β.

Luangmonkong T, Suriguga S, Adhyatmika A, Adlia A, Oosterhuis D, Suthisisang C, de Jong KP, Mutsaers HAM, Olinga P. Luangmonkong T, et al. Among authors: oosterhuis d. Toxicol Appl Pharmacol. 2018 Sep 15;355:127-137. doi: 10.1016/j.taap.2018.07.001. Epub 2018 Jul 3. Toxicol Appl Pharmacol. 2018. PMID: 30008374

8

Regional Differences in Human Intestinal Drug Metabolism.

Iswandana R, Irianti MI, Oosterhuis D, Hofker HS, Merema MT, de Jager MH, Mutsaers HAM, Olinga P. Iswandana R, et al. Among authors: oosterhuis d. Drug Metab Dispos. 2018 Dec;46(12):1879-1885. doi: 10.1124/dmd.118.083428. Epub 2018 Oct 1. Drug Metab Dispos. 2018. PMID: 30275119

9

A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices.

Prins GH, Luangmonkong T, Oosterhuis D, Mutsaers HAM, Dekker FJ, Olinga P. Prins GH, et al. Among authors: oosterhuis d. Nutrients. 2019 Feb 27;11(3):507. doi: 10.3390/nu11030507. Nutrients. 2019. PMID: 30818824 Free PMC article.

10

Ex Vivo Model in Cholestasis Research.

Karsten REH, Oosterhuis D, van Wijk LA, Olinga P. Karsten REH, et al. Among authors: oosterhuis d. Methods Mol Biol. 2019;1981:351-362. doi: 10.1007/978-1-4939-9420-5_23. Methods Mol Biol. 2019. PMID: 31016666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page